TY - JOUR
T1 - Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation
AU - Svatek, Robert S.
AU - Sims, Robert
AU - Anderson, J. Kyle
AU - Abdel-Aziz, Khaled
AU - Cadeddu, Jeffrey A.
PY - 2006/3
Y1 - 2006/3
N2 - Objectives. The interpretation of radiographic findings in renal tumors treated with minimally invasive modalities, such as radiofrequency ablation (RFA), is critical for assessing treatment adequacy. Magnetic resonance imaging (MRI) is commonly used for patients with renal insufficiency or contrast allergy. Because the MRI experience with renal RFA is limited, we reviewed our experience and report the unique MRI characteristics of RFA-treated renal tumors. Methods. A single-institution database of renal RFA was reviewed to identify patients followed up with MRI. A radiologist and urologist retrospectively reviewed all MRI scans to identify the characteristic lesion findings after RFA. Results. Eleven patients (12 tumors) treated by RFA were followed up with MRI examinations. The mean follow-up was 10 months. The mean tumor size at ablation was 2.4 cm, with minimal reduction over time. Ablated lesions were characterized by high signal intensity on T1-weighted images, low signal intensity on T2-weighted images, and an absence of contrast enhancement. Of the patients treated by percutaneous RFA, 71% developed a characteristic peritumor halo, seen as a rim of low signal intensity on T1-weighted and T2-weighted images, surrounding a zone of perinephric fat just external to the ablated area. Two lesions demonstrated enhancement on the initial postablation MRI scan, indicating incomplete ablation. Conclusions. The MRI characteristics of successfully ablated renal tumors include the absence of enhancement, minimal size reduction over time, and high and low signal intensity on T1-weighted and T 2-weighted imaging, respectively. Knowledge of these findings can aid radiologists and urologists in correctly assessing the success of RFA for kidney lesions.
AB - Objectives. The interpretation of radiographic findings in renal tumors treated with minimally invasive modalities, such as radiofrequency ablation (RFA), is critical for assessing treatment adequacy. Magnetic resonance imaging (MRI) is commonly used for patients with renal insufficiency or contrast allergy. Because the MRI experience with renal RFA is limited, we reviewed our experience and report the unique MRI characteristics of RFA-treated renal tumors. Methods. A single-institution database of renal RFA was reviewed to identify patients followed up with MRI. A radiologist and urologist retrospectively reviewed all MRI scans to identify the characteristic lesion findings after RFA. Results. Eleven patients (12 tumors) treated by RFA were followed up with MRI examinations. The mean follow-up was 10 months. The mean tumor size at ablation was 2.4 cm, with minimal reduction over time. Ablated lesions were characterized by high signal intensity on T1-weighted images, low signal intensity on T2-weighted images, and an absence of contrast enhancement. Of the patients treated by percutaneous RFA, 71% developed a characteristic peritumor halo, seen as a rim of low signal intensity on T1-weighted and T2-weighted images, surrounding a zone of perinephric fat just external to the ablated area. Two lesions demonstrated enhancement on the initial postablation MRI scan, indicating incomplete ablation. Conclusions. The MRI characteristics of successfully ablated renal tumors include the absence of enhancement, minimal size reduction over time, and high and low signal intensity on T1-weighted and T 2-weighted imaging, respectively. Knowledge of these findings can aid radiologists and urologists in correctly assessing the success of RFA for kidney lesions.
UR - http://www.scopus.com/inward/record.url?scp=33644784787&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644784787&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2005.09.046
DO - 10.1016/j.urology.2005.09.046
M3 - Article
C2 - 16504265
AN - SCOPUS:33644784787
SN - 0090-4295
VL - 67
SP - 508
EP - 512
JO - Urology
JF - Urology
IS - 3
ER -